# Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement

> **NCT06818630** · NA · COMPLETED · sponsor: **L'Oréal Taiwan Co., Ltd** · enrollment: 35 (actual)

## Conditions studied

- Skin Quality Improvement

## Interventions

- **OTHER:** SkinCeuticals combination skin care products
- **OTHER:** Regular skin care procedure

## Key facts

- **NCT ID:** NCT06818630
- **Lead sponsor:** L'Oréal Taiwan Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-29
- **Primary completion:** 2024-10-29
- **Final completion:** 2025-01-23
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06818630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06818630, "Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06818630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*